Non-profits fill gaps in the broken market for antibiotics

  08 December 2020

Push-pull action will be needed if the battle against antimicrobial resistance is to succeed. The pull has to come from financial incentives to repair the broken market for antibiotics and make it worthwhile for the pharmaceutical industry to bring promising drugs to market.

Yet despite signs that governments and the industry are beginning to tackle this — such as by finding ways to pay companies for developing drugs that will not be used under normal circumstances — there is still a long way to go. But the push side is looking more encouraging. A ferment of research is producing new antibiotics, using technologies ranging from conventional “small molecule” chemistry to more biological approaches that enlist other microbes or viruses to attack harmful bacteria.

Further reading: Financial Times
Author(s): Clive Cookson
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed